Objective To summarize the progress of clinical research on triple-negative breast cancer (TNBC).
目的综述三阴乳腺癌(TNBC)的临床研究进展。
We studied the expression of programmed cell death protein 1 (PD-1) and its ligand (PD-L1) in TNBC.
作者研究了程序性细胞死亡蛋白1(PD-1)及其配体(PD-L1)在三阴性乳腺癌中的表达情况。
We studied the expression of programmed cell death protein 1 (PD-1) and its ligand (PD-L1) in TNBC.
作者研究了程序性细胞死亡蛋白1(PD-1)及其配体(PD-L1)在三阴性乳腺癌中的表达情况。
应用推荐